BIIB
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FBIIB.O%2Fkey-developments%2Farticle%2F2480305&ei=oIaaUrm3H4Hl0gG83wE&usg=AFQjCNFjEMiYAPY-pDhforznwjaLFiA8jw
Biogen Idec Inc To Acquire Stromedix
Tuesday, 14 Feb 2012 08:30am EST
Biogen Idec Inc and Stromedix, Inc. announced that they have entered into a definitive agreement under which Biogen Idec will acquire Stromedix Inc., a privately held biotechnology company focused on therapies for fibrosis and organ failure. Under the terms of the agreement, Biogen Idec will make an upfront cash payment of $75 million and additional contingent value payments of up to $487.5 million based on the achievement of certain development and approval milestones across multiple indications.Â 
